MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression

Journal of Psychiatry and Neuroscience

Volumn 41, Issue 5, 2016, Pages 342-353

  Aschrafi, Armaz ^a,c   Verheijen, Jan M ^a,f,g   Gordebeke, Peter M ^a   Olde Loohuis, Nikkie F ^a   Menting, Kelly ^a   Jager, Amanda ^a   Palkovits, Miklos ^b   Geenen, Bram ^a   Kos, Aron ^a   Martens, Gerard J M ^a   Glennon, Jeffrey C ^a   Kaplan, Barry B ^c   Gaszner, Balázs ^d   Kozicz, Tamas ^a,e  

^a RADBOUD UNIVERSITY   (Netherlands)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF PÉCS   (Hungary)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^g UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; CORTICOSTERONE; MICRORNA; MICRORNA 326; NEUROPEPTIDE; UNCLASSIFIED DRUG; UROCORTIN I; MESSENGER RNA; MIRN326 MICRORNA, HUMAN; MIRN326 MICRORNA, RAT; UCN1 PROTEIN, HUMAN; UCN1 PROTEIN, RAT; UROCORTIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; EDINGER WESTPHAL NUCLEUS; FORCED SWIM TEST; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUCIFERASE ASSAY; MALE; MESENCEPHALON; MIDDLE AGED; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PSYCHIATRIC DIAGNOSIS; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; SUICIDE ATTEMPT; ANIMAL; BINDING SITE; CHRONIC DISEASE; COMPUTER SIMULATION; DISEASE MODEL; MENTAL STRESS; METABOLISM; NERVE CELL; SUICIDE; WISTAR RAT;

ADULT; ANIMALS; BINDING SITES; CELLS, CULTURED; CHRONIC DISEASE; COMPUTER SIMULATION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; MALE; MESENCEPHALON; MICRORNAS; MIDDLE AGED; NEURONS; RATS, WISTAR; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SUICIDE; UROCORTINS;

EID: 84984856575     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.150154     Document Type: Article

References (56)

1. Turecki G. The molecular bases of the suicidal brain. Nat Rev Neurosci 2014;15:802-16.
2. Turecki G. Epigenetics and suicidal behavior research pathways. Am J Prev Med 2014;47(Suppl 2):S144-51.
3. Levinson DF. The genetics of depression: a review. Biol Psychiatry 2006;60:84-92.
4. de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adapta-tion to disease. Nat Rev Neurosci 2005;6:463-75.
5. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894-902.
6. Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 2010;15:574-88.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
8. Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009;11:228-34.
9. Zeng Y, Cullen BR. Sequence requirements for micro RNA process-ing and function in human cells. RNA 2003;9:112-23.
10. Lee Y, Jeon K, Lee JT, et al. MicroRNA maturation: stepwise pro-cessing and subcellular localization. EMBO J 2002;21:4663-70.
11. Schouten M, Aschrafi A, Bielefeld P, et al. microRNAs and the regu-lation of neuronal plasticity under stress conditions. Neuroscience 2013;241:188-205.
12. Issler O, Chen A. Determining the role of microRNAs in psychiatric disorders. Nat Rev Neurosci 2015;16:201-12.
13. Uchida S, Nishida A, Hara K, et al. Characterization of the vulnera-bility to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid recep-tor. Eur J Neurosci 2008;27:2250-61.
14. Meerson A, Cacheaux L, Goosens KA, et al. Changes in brain microRNAs contribute to cholinergic stress reactions. J Mol Neurosci 2010;40:47-55.
15. Katsuura S, Kuwano Y, Yamagishi N, et al. MicroRNAs miR-144/ 144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neurosci Lett 2012;516:79.
16. van der Doelen RH, Kozicz T, Homberg JR. Adaptive fitness; early life adversity improves adult stress coping in heterozygous sero-tonin transporter knockout rats. Mol Psychiatry 2013;18:1244-5.
17. Ryabinin AE, Tsoory MM, Kozicz T, et al. Urocortins: CRF’s sib-lings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol 2012;46:349-57.
18. Kozicz T, Sterrenburg L, Xu L. Does midbrain urocortin 1 matter? A 15-year journey from stress (mal)adaptation to energy metabolism. Stress 2011;14:376-83.
19. Kozicz T, Bittencourt JC, May PJ, et al. The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J Comp Neurol 2011;519:1413-34.
20. Kozicz T. On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. Gen Comp Endocrinol 2007;153:235-40.
21. Joëls M, Baram TZ. The neuro-symphony of stress. Nat Rev Neurosci 2009;10:459-66.
22. Vetter DE, Li C, Zhao L, et al. Urocortin-deficient mice show hear-ing impairment and increased anxiety-like behavior. Nat Genet 2002;31:363-9.
23. Kozicz T, Tilburg-Ouwens D, Faludi G, et al. Gender-related uro-cortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience 2008;152:1015-23.
24. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992;16:525-34.
25. Gaszner B, Csernus V, Kozicz T. Urocortinergic neurons respond in a differentiated manner to various acute stressors in the Edinger- Westphal nucleus in the rat. J Comp Neurol 2004;480:170-9.
26. Son JH, Kawamata H, Yoo MS, et al. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons 54. J Neurochem 2005;94:1040-53.
27. Okere B, Xu L, Roubos EW, et al. Restraint stress alters the secre-tory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res 2010;1317:92-9.
28. Gaszner B, Jensen KO, Farkas J, et al. Effects of maternal separa-tion on dynamics of urocortin 1 and brain-derived neurotrophic factor in the rat non-preganglionic Edinger-Westphal nucleus. Int J Dev Neurosci 2009;27:439-451.
29. Aschrafi A, Schwechter AD, Mameza MG, et al. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxida-tive phosphorylation in the axons of sympathetic neurons. J Neurosci 2008;28:12581-90.
30. Bloem B, Xu L, Morava E, et al. Sex-specific differences in the dy-namics of cocaine- and amphetamine-regulated transcript and nesfatin-1 expressions in the midbrain of depressed suicide victims vs. controls. Neuropharmacology 2012;62:297-303.
31. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20.
32. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005;52:90-110.
33. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010;13:1161-9.
34. Nemeroff CB, Widerlov E, Bissette G, et al. Elevated concentra-tions of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984;226:1342-4.
35. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr Rev 1996;17:187-205.
36. Xu L, Bloem B, Gaszner B, et al. Stress-related changes in the activity of cocaine- and amphetamine-regulated transcript and nesfatin neurons in the midbrain non-preganglionic Edinger-Westphal nu-cleus in the rat. Neuroscience 2010;170:478-88.
37. Kim J, Krichevsky A, Grad Y, et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci U S A 2004;101:360-5.
38. Dwivedi Y. Evidence demonstrating role of microRNAs in the etio-pathology of major depression. J Chem Neuroanat 2011;42:142-56.
39. Niwa R, Slack FJ. The evolution of animal microRNA function. Current Opinion in Genetics &. Development 2007;17:145-50.
40. Rinaldi A, Vincenti S, De Vito F, et al. Stress induces region specific alterations in microRNAs expression in mice. Behav Brain Res 2010;208:265-9.
41. Hunsberger JG, Austin DR, Chen G, et al. MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromolecular Med 2009;11:173-82.
42. Issler O, Haramati S, Paul ED, et al. MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron 2014;83:344-60.
43. Uchida S, Hara K, Kobayashi A, et al. Early life stress enhances be-havioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of ro-dents. J Neurosci 2010;30:15007-18.
44. Haramati S, Navon I, Issler O, et al. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci 2011;31:14191-203.
45. Gui J, Tian Y, Wen X, et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci 2011;120:183-93.
46. Ding X, Ding J, Ning J, et al. Circulating microRNA-122 as a poten-tial biomarker for liver injury. Mol Med Rep 2012;5:1428-32.
47. Alvarez-Erviti L, Seow Y, Schapira AH, et al. Lysosomal dysfunc-tion increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 2011;42:360-7.
48. Lakhal S, Wood MJ. Exosome nanotechnology: an emerging para-digm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays 2011;33:737-741.
49. Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011;8:467-77.
50. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell 2012;148:1172-87.
51. Weis SM. Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 2008;15:243-9.
52. Guilloux JP, Bassi S, Ding Y, et al. Testing the predictive value of periph-eral gene expression for nonremission following citalopram treatment for major depression. Neuropsychopharmacology 2015;40:701-710.
53. Mamdani F, Berlim MT, Beaulieu MM, et al. Gene expression bio-markers of response to citalopram treatment in major depressive disorder. Transl Psychiatry 2011;1:e13.
54. Kefas B, Comeau L, Floyd DH, et al. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci 2009;29:15161-8.
55. Meng F, Henson R, Lang M, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006;130:2113-29.
56. Ferretti E, De SE, Po A, et al. MicroRNA profiling in human medullo-blastoma. Int J Cancer 2009;124:568-77.